Teladoc Health, Inc. · NYSE:TDOC

Teladoc Health — Investor Day (November 2017)

103 slides from Teladoc Health's investor day presentation, Nov 20, 2017

Slide 1: Agenda
Agenda Welcome & Overview Jason Gorevic, Chief Executive Officer Integrated Commercial Strategy Peter McClennen, President Clinical Quality & Health Services Lewis Levy, MD, Chief Medical Officer Engagement Strategy Stephany Verstraete, Chief Marketing Officer Lunch Product Vision Dan Trencher, SVP
Slide 3: Leading the Way in Virtual Care Delivery
Leading the Way in Virtual Care Delivery • At Teladoc, we are At Teladoc, we are transforming how people transforming how people access access healthcare globally. healthcare globally. • We provide a new kind of We provide a new kind of healthcare healthcare experience: experience: one with better c
Slide 4: Investment Highlights
Investment Highlights The Only Transformative Virtual Care Delivery Solution Industry Leader with Strong Competitive Positioning TAM Increases to $57BN(1-7) with Addition of Expert Opinions, Markets Ripe for Disruption Accelerating Utilization Rates Across Populations Comprehensive Product Suite Tai
Slide 5: Teladoc at a Glance
Teladoc at a Glance Highlights Revenue (M) Visits (K) 73% 10,000+ $232 1,425 Revenue CAGR Total Clients 952 (2015-2017E) $123 576 $77 (1) (2) (1) 2015 2016 2017E 2015 2016 2017E 300+ Fortune 1000 Clients Members (M) PEPM Includes Best Doctors (2) $0.91 23 18 $0.68 35+ 200+ 12 $0.52 Health Plan Hospi
Slide 6: Execution on Growth Strategy
Execution on Growth Strategy Expand Footprint & Expand Scope of Expand Specialties Expand Clinical Penetration Products & Use Cases Services ✓ o New Accounts & Channels ✓ o Behavioral Health o Health Kiosk o Home Care ✓ o Existing Health Plans ✓ o Dermatology ✓ o Mobile Apps / Hubs ✓ o Post Discharg
Slide 7: Executing Multi-Faceted Growth Strategy
Executing Multi-Faceted Growth Strategy Proven ability to grow organically and to acquire and integrate in a disciplined fashion 2013: Jan 2015: July 2015: 2015: 1Q 2017: July 2017: Launched: Launched: Launched Initial Partnerships: Acquisition Public Offering Acquisition • Mobile App v1 • Behaviora
Slide 8: TAM Expansion & Significant Penetration Opportunity
TAM Expansion & Significant Penetration Opportunity 5.1M Annual Incidence of Top Expert Opinion Conditions (1) Expert Opinion $28B $5,500 Case Rate (2) 1.25B Annual Visits (3) Ambulatory Care $17B 33% Treatable Via Telehealth (4) $40 Average Visit Fee (5) 168M Annual Visits (6) Behavioral Health $12
Slide 9: Redefined Competitive Landscape
Redefined Competitive Landscape Diversified Distribution Second Opinion Virtual Urgent Care Competitor Competitor Competitor E F Point Solution A Full Continuum of Care Competitor B Competitor Competitor G D Competitor C Note: Competitor information represents Teladoc management estimates and other
Slide 10: Revenue Upside w/ Long Term Partner
Revenue Upside w/ Long Term Partner New Contract Overview Economics with Upside Expanded Reach and Scope • Renewal and extension of Fully Insured contract • New products to all segments: Behavioral Health, • Expected to be revenue-neutral for 2018; Positive for 2019 Dermatology and Caregiver • Incre
Slide 11: Case Study: Health Plan with Utilization-Based Upside
Case Study: Health Plan with Utilization-Based Upside Diverse population requires custom Visit Growth engagement strategies Significant expansion of organizational support for Teladoc in their core strategy Revenue upside as utilization grows 20161 Year 2017 YearEST 2 © 2002-2017 Teladoc, Inc. All r
Slide 14: Peter McClennen
Peter McClennen President, Teladoc — CEO — President Population Health Management — President — Global General Manager / VP, GM Global Marketing / Product Management © 2002-2017 Teladoc, Inc. All rights reserved. 14
Slide 16: Misdiagnosis: A Global Health Challenge
Misdiagnosis: A Global Health Challenge “ Most Americans will encounter at least one diagnostic error in their lifetime, sometimes with severe consequences for their physical & mental “ health. – Institute of Medicine 26% 1/3 3rd of diagnoses were of all healthcare costs in the U.S. leading cause of
Slide 17: Best Doctors Value Proposition
Best Doctors Value Proposition Best Doctors identifies and solves the most complex, critical, and costly problems in health care by combining data analytics and top clinical talent with our highly personal methodology across a global network. Correct or Correct or refined diagnoses (1) 44% refined t
Slide 18: What is Best Doctors?
What is Best Doctors? Network 50,000+ experts globally across 450+ specialties Solution Diverse product portfolio for 800+ clients Serving global markets: employer, health plan, consumer, health system and financial services Platform 97% 98% ~40% 2:1+ Client Retention Client International Customer R
Slide 19: Best Doctors Global Business Model
Best Doctors Global Business Model Employer – PEPM Employee benefit and ROI Global Financial Services – PMPM Value-added differentiator Complex Cases – Utilization Based ROI thru improved outcomes © 2002-2017 Teladoc, Inc. All rights reserved. 19
Slide 21: Solving the Most Complex & Costliest Cases
Solving the Most Complex & Costliest Cases Percent of Cost Positive Health Plan Reception Critical Care 3% 37% $36K: Avg. savings / expert review $116K: Avg. savings / critical care case Chronic Care 20% 40% 77% 23% $472: Avg. claims savings / visit Episodic Care $46: Avg. productivity savings / vis
Slide 22: Teladoc's Unique Commercial Focus
Teladoc’s Unique Commercial Focus Comprehensive approach to virtual care delivery Teladoc’s Markets Metrics Driven EMPLOYER HEALTH PLAN HEALTH SYSTEMS Management Benefits Self-Insured Providers Demonstrable ROI Fully Insured Hospitals Platform Based Employer of Choice ACO, PCMH IDNs Solution Whitesp
Slide 23: Realizing Our Integrated Offering
Realizing Our Integrated Offering • Built new dedicated Best Doctors mobile app Measuring Success Access • Integrated TD and BD single solution – mobile/web • Launched integrated experience – ahead of schedule! • Increase revenue per Member & Visit • Positive utilization • Cross-selling model establ
Slide 24: Massive Whitespace
Massive Whitespace $200M+ opportunity to cross-sell core products in existing U.S. Employer book of business $200M+ White space calculated as (BD U.S. Paid Members without Teladoc access X average Teladoc PEPM) + (Teladoc U.S. Paid Members without Best Doctors access X average Best Doctors PEPM) + (
Slide 25: Cross-Selling Integrated Solution: Early Wins
Cross-Selling Integrated Solution: Early Wins + Net New Cross-Sell Cross-Sell Takeaways TD and BD Clients Core Offering Add-On Products from Incumbents 20+ wins representing several million dollars of revenue © 2002-2017 Teladoc, Inc. All rights reserved. 25
Slide 29: Access to the Best Doctors Globally
Access to the Best Doctors Globally 50,000+ 4 medical Global Medical experts Advisory Boards 100+ 450 countries specialties & sub-specialties © 2002-2017 Teladoc, Inc. All rights reserved. 29
Slide 30: Expert Opinion: Clinical Process
Expert Opinion: Clinical Process Rigor and comprehensive approach delivers superior quality INFORMATION CLINICAL SUMMARY EXPERT REVIEW GATHERING Best Doctors Medical Team & REPORT Clinical Intake, records Best Doctors Expert collection, pathology review Physicians Best Doctors World- Clinical Impact
Slide 31: Expert Opinion: Member Experience
Expert Opinion: Member Experience Sophisticated analytics married with seamless member experience Best Doctors Clinical Best Doctor Member Analytics identify population for intervention Best Doctors Support Staff © 2002-2017 Teladoc, Inc. All rights reserved. 31
Slide 32: Best Doctors Patient Case Study
Best Doctors Patient Case Study Clinical Overview – Pleural Effusion 60+ year-old man with history of chronic myelogenous leukemia on Dasatinib therapy Consulted with primary care physician, oncologist, pulmonologist, and two thoracic surgeons Multiple procedures proven ineffective, member being man
Slide 33: Best Doctors Results
Best Doctors Results Musculoskeletal Cancers Heart Diseases Gastrointestinal Lower back Prostate Cardiac dysrhythmias Disorders Cervical spine Breast Coronary artery disease Inflammatory bowel disease Knee or hip replacement Colorectal Esophageal disorders 27% 16% 7% 8% of total cases of total cases
Slide 34: Accelerating Quality of Cancer Care
Accelerating Quality of Cancer Care 29 hours per work day The Best Doctors to stay up-to-date with the Watson can read network includes world- latest medical literature renowned oncologists in 200 million over 75 oncology documents in 3 Average 17 years specialties and sub- seconds. for science to b
Slide 35: Teladoc's Unmatched Clinical Quality
Teladoc’s Unmatched Clinical Quality Building Building market leadership on Market Leadership unrivaled on aofFoundation foundation of Clinical Quality medical quality • Access to global experts, supplementing local supply to improve outcomes • Single platform enables processes that promote adherenc
Slide 37: Stephany Verstraete
Stephany Verstraete Chief Marketing Officer — Chief Marketing Officer — VP Global Customer Relationship marketing, VP Online Marketing — VP Online Marketing ad Business Development © 2002-2017 Teladoc, Inc. All rights reserved. 37
Slide 38: Path to Inflection Point
Path to Inflection Point Early Mainstream Sustained Adopters Acceptance Behavior Change Old Model Nascent Hi-Growth Mainstream © 2002-2017 Teladoc, Inc. All rights reserved. 38
Slide 40: Phase 1: Reaching Early Adopters
Phase 1: Reaching Early Adopters Early Adopters One primary acquisition channel Awareness Old Model Nascent Hi-Growth Mainstream © 2002-2017 Teladoc, Inc. All rights reserved. 40
Slide 41: Teladoc Media Mix
Teladoc Media Mix pre-2016 Word of mouth In the home Social media In the inbox On the go When need arises On site [<Made available by:>] <<Card Name>> Did you know? Any time you need a doctor’s care, you’ve got Teladoc. 24/ 7/ 365 care , for: Licensed doctors d Cold & flu al ler gies, ear infections
Slide 42: Phase 2: Mainstream Acceptance
Phase 2: Mainstream Acceptance Mainstream Acceptance Multi channel media mix Awareness Old Model Nascent Hi-Growth Mainstream © 2002-2017 Teladoc, Inc. All rights reserved. 42
Slide 43: Teladoc Media Mix
Teladoc Media Mix 2016-2017 Word of mouth In the home Social media In the inbox On the go [<Made available by:>] <<Card Name>> When need arises On site Did you know? Any time you need a doctor’s care, you’ve got Teladoc. 24/ 7/ 365 care , for: Licensed doctors d Cold & flu al ler gies, ear infection
Slide 45: Sophisticated Audience Intelligence Fuels Reach
Sophisticated Audience Intelligence Fuels REACH Addressable Teladoc Population Product Eligibility General medical Behavioral Health Best Doctors © 2002-2017 Teladoc, Inc. All rights reserved. 45
Slide 46: Sophisticated Audience Intelligence Fuels Targeting
Sophisticated Audience Intelligence Fuels TARGETING Teladoc Target Audience Product Eligibility General medical Behavioral Health Best Doctors © 2002-2017 Teladoc, Inc. All rights reserved. 46
Slide 47: Sophisticated Audience Intelligence Fuels Personalization
Sophisticated Audience Intelligence Fuels PERSONALIZATION Teladoc Target Audience by Media & Message Targeting Working Moms with young kids Business Travelers Students Urban millennials Manufacturing © 2002-2017 Teladoc, Inc. All rights reserved. 47
Slide 49: Sophisticated Engagement Strategies Yield Stronger Results
Sophisticated Engagement Strategies Yield Stronger Results ✓ Expanded reach & targeting ✓ Multiple touchpoints per MONTH ✓ Lower cost per visit 2x lift “surround 50% >1M sound” vs YoY brand app single channel traffic growth downloads only © 2002-2017 Teladoc, Inc. All rights reserved. 49
Slide 50: Install Base Utilization Tailwinds
Install Base Utilization Tailwinds Utilization Trends by Cohort (1) 20% 10% 0% Jan '17 Current Jan '17 Current Jan '17 Current 2016 Cohort 2015 Cohort 2013/2014 Cohort Utilization increases with long term investment in consumer engagement (1) Cohort by calendar year refers to membership base associa
Slide 51: Teladoc Media Mix: What's Next?
Teladoc Media Mix What’s next? Online When watching When streaming Word of Mouth When listening Social media In the home On the go In the inbox When need arises On site © 2002-2017 Teladoc, Inc. All rights reserved. 51
Slide 55: 20 Minute Break
Welcome & Overview Jason Gorevic, Chief Executive Officer Integrated Commercial Strategy Peter McClennen, President Clinical Quality & Health Services Lewis Levy, MD, Chief Medical Officer Engagement Strategy Stephany Verstraete, Chief Marketing Officer Lunch Product Vision Dan Trencher, SVP Product
Slide 58: Path to Inflection Point: Product
Path to Inflection Point: Product Early Mainstream Sustained Adopters Acceptance Behavior Change Awareness Single channel Multi channel Repeat usage/ expands win the choice top of funnel Experience Must be better Comprehensive, Co-existence than engrained choice behavior Product Integrated Full Core
Slide 62: Building a Virtual Healthcare Ecosystem
Building a Virtual Healthcare Ecosystem Expansive Clinical Services Integration with HC Ecosystem Data & Analytics © 2002-2017 Teladoc, Inc. All rights reserved. 62
Slide 63: Building a Virtual Healthcare Ecosystem
Building a Virtual Healthcare Ecosystem Expansive Clinical Services Integration with HC Ecosystem Data & Analytics Devices & Wearables © 2002-2017 Teladoc, Inc. All rights reserved. 63
Slide 64: Building a Virtual Healthcare Ecosystem
Building a Virtual Healthcare Ecosystem Expansive Clinical Services Integration with HC Ecosystem Ubiquitous Data & Entry Analytics Points Devices & Wearables © 2002-2017 Teladoc, Inc. All rights reserved. 64
Slide 65: Building a Virtual Healthcare Ecosystem
Building a Virtual Healthcare Ecosystem Expansive Clinical Services Surround Integration Sound with HC Engagement Ecosystem Ubiquitous Data & Entry Analytics Points Devices & Wearables © 2002-2017 Teladoc, Inc. All rights reserved. 65
Slide 66: Integrated, Personalized, Relevant
Integrated, Personalized, Relevant I want to talk to a Virtual Care Access doctor now Smart Information & I need a Guidance Decision Support specialist My Teladoc Tools I want to track my health © 2002-2017 Teladoc, Inc. All rights reserved. 66
Slide 67: An Expanding Product Portfolio
An Expanding Product Portfolio I want to address my anxiety My child woke up Complexity, Cost this morning with a fever Higher  Volume  Lower © 2002-2017 Teladoc, Inc. All rights reserved. 67
Slide 68: An Expanding Product Portfolio
An Expanding Product Portfolio Is my husband’s diagnosis and plan right? What will recovery be like from hip and knee procedure? Should I have it? Complexity, Cost Is this the best treatment plan for my cancer? Higher  Volume  Lower © 2002-2017 Teladoc, Inc. All rights reserved. 68
Slide 70: Innovative New Products
Innovative New Products Innovation Exclusive collaboration with industry leading partner • Critical cost containment Proactive • Analytics driven insights innovation based on • Global impact industry trend • Cross-sell opportunities #1 industry Specialty Rx cost priority © 2002-2017 Teladoc, Inc. Al
Slide 73: Vision – Illustrative Integrated User Experience
Vision – Illustrative Integrated User Experience Using technology, data and AI to help guide… © 2002-2017 Teladoc, Inc. All rights reserved. 73
Slide 74: Vision – Illustrative Integrated User Experience
Vision – Illustrative Integrated User Experience …a curated set of services tailored to the individual Quick Visit 2nd Opinion My Care Team Find Best Doctor © 2002-2017 Teladoc, Inc. All rights reserved. 74
Slide 76: Chet Burrell
Chet Burrell President & Chief Executive Officer, CareFirst Best Doctors Client since 2013 — President & CEO — President & CEO — Executive Vice President © 2002-2017 Teladoc, Inc. All rights reserved. 76
Slide 77: About CareFirst
About CareFirst • Largest healthcare insurer in Mid-Atlantic region serving 3.2M members • Launched the nation’s largest Patient-Centered Medical Home (PCMH) program of its kind • More than 4,400 PCPs across ~400 clinics • 1.1M Members • $5B Annual spending • Mission driven leadership What We Needed
Slide 78: Best Doctors Partnership
Best Doctors Partnership Products Clinical Impact Reasons for coming to Best Doctors 41% Expert Opinion Average change in diagnosis Critical Care 71% Average change in treatment Tangible Results 20%+ $10M 94% CAGR of cases since 2013 2017 Estimated Savings Member Satisfaction © 2002-2017 Teladoc, In
Slide 79: Matt Ponicall
Matt Ponicall SVP, Senior Benefits Consultant, Bank of America Teladoc Client since 2015 — Senior Vice President — Planning and Strategy Manager — Welfare Consultant © 2002-2017 Teladoc, Inc. All rights reserved. 79
Slide 80: Partnership Background and Key Statistics
Partnership Background and Key Statistics Partnership began in 2015 through our relationship with Aetna and has since expanded to all national self-funded plans 135K ~2X Employees Visits 325K Members 2016 vs. 2015 Note: images are illustrative © 2002-2017 Teladoc, Inc. All rights reserved. 80
Slide 81: Helping Us Achieve Critical Objectives
Helping Us Achieve Critical Objectives Objective Results √ 1 Increase awareness and utilization of telehealth Members are registering and utilizing the service 2 Provide convenient, accessible care at a low cost √ Members are receiving care when they want it and at a lower cost 3 √ Monitor administr
Slide 82: Multi-Year Execution Plan
Multi-Year Execution Plan 2017 2018 2019 New Hires Jun – Jul 3Q’17 through 2019 New hire events Welcome letters College Students / Recent Graduates Increase 4Q’17 Custom communications Aug 18 Back to school initiatives Awareness Onsite Events in Select Markets Kinsa Promotion – Dallas, TX 3Q’17 1Q’1
Slide 84: Alan Roga, MD
Alan Roga, MD President, Health System Market — Founder & CEO — Chairman, Department Formerly Scottsdale Healthcare of Emergency Medicine Scot t sdale Emergency — President Associat es © 2002-2017 Teladoc, Inc. All rights reserved. 84
Slide 85: Value of Telehealth to the Health System Market
Value of Telehealth to the Health System Market FINANCIAL COORDINATED CARE MARKET SHARE • Population health management • Increase provider capacity • Acquire & retain patients • More cost effective care • Systems integration • Strengthen brand • Enhance efficiency • Expand reach • Service to communi
Slide 86: Rapid Acceleration of Telehealth Demand in Health System Market
Rapid Acceleration of Telehealth Demand in Health System Market 83% 80% 81% Rate telehealth as a Telehealth programs in Dedicated person in high priority initiative place less than 3 years charge of consumer telehealth program Note: Teladoc Consumer Telehealth 2016 Benchmark Survey Results © 2002-20
Slide 87: Teladoc Health System Solution
Teladoc Health System Solution DEDICATED LICENSABLE OPERATIONAL DIVISION TECHNOLOGY SUPPORT Workflow / Data Integration Private-Label Software Engagement Marketing End-to-End Operations Commercialization Provider Network Teladoc’s telehealth technology platform and licensable software solution has e
Slide 88: Teladoc Health System Platform & Pricing
Teladoc Health System Platform & Pricing Solution Summary • Dedicated instance of private-labeled, cloud-based solution • Call Center, TPN and Marketing Services • Pricing components: Professional Services, Annual License and Transaction fees © 2002-2017 Teladoc, Inc. All rights reserved. 88
Slide 89: Industry's Most Comprehensive Solution
Industry’s Most Comprehensive Solution Teladoc Own Instance End-End Brand Operations Dedicated Marketing Division Expertise PLATFORM Teladoc Nimble Configurable Network © 2002-2017 Teladoc, Inc. All rights reserved. 89
Slide 90: Teladoc Health System Partners and Recent Wins
Teladoc Health System Partners and Recent Wins Number of Hospitals Recent Wins 206 90 54 23 Partners Jan-15 Jan-16 Jan-17 Current © 2002-2017 Teladoc, Inc. All rights reserved. 90
Slide 92: Teladoc: Financial Summary
Teladoc: Financial Summary Revenue (M) Visits Visits(000s) (K) $304 Utilization 7% 4Q Run-Rate (1) 4Q Run-Rate (1) 6% $232 5% 1,700 4% 1,425 $123 952 $77 576 $44 299 (2) 2014 2015 2016 2017E (2) 2014 2015 2016 2017E Members (M) PEPM Includes Best Doctors (3) $0.91 23 $0.68 18 $0.52 12 $0.45 8 $0.40
Slide 93: Teladoc's Robust Financial Outlook Driven by Strong Fundamentals
Teladoc’s Robust Financial Outlook Driven by Strong Fundamentals 45% YoY Organic Growth $76.0 $68.7 $42.9 $44.6 $37.4 $32.4 $26.9 $26.5 $20.0 $22.6 (1) (2) 3Q'15 4Q'15 1Q'16 2Q'16 3Q'16 4Q'16 1Q'17 2Q'17 3Q'17 4Q'17E vs. Consensus $0.7 $0.6 $0.2 ($1.6) $0.0 $0.3 $0.6 $0.3 $1.2 $76M (Median) 3.7% 2.5
Slide 94: Teladoc Delivering Positive Adjusted EBITDA
Teladoc Delivering Positive Adjusted EBITDA Proud to be delivering on commitment at IPO Revenue ($M) $232 200% Adjusted EBITDA ($M) Opex % Revenue 160% $123 120% $69 $76 $77 $43 $45 $44 $20 80% ($1) $2 ($9) ($5) ($5) ($12) ($14) 40% ($48) ($40) (1) (1) 0% 1Q'17 2Q'17 3Q'17 4Q'17E 2013 2014 2015 2016
Slide 95: Teladoc: Positive PEPM Trends
Teladoc: Positive PEPM Trends Consolidated Average PEPM (1) Expected to increase ~$0.05 to $0.10 per annum $0.91 Total Company PEPM as Reported PEPM as Reported, Excl. Best Doctors $0.68 $0.22 1Q'13 3Q'17 Note: Financial information as of September 30, 2017. (1) Represents historical, as reported ba
Slide 96: Teladoc – Key Metrics and Drivers
Teladoc – Key Metrics and Drivers Commencing Q1 2018, we will bolster our reporting to enhance transparency into our global business Key Performance Indicators (1) Definition • TD and BD U.S. Members in Access Fee (PEPM/PMPM) pricing arrangements U.S. Paid Members (“USPM”) • Excludes Aetna FI, Ameri
Slide 97: Teladoc – Key Revenue Metrics
Teladoc – Key Revenue Metrics Commencing Q1 2018, we will bolster our reporting to enhance transparency into our global business Key Revenue Metrics (1) Definition • U.S. Paid Members (USPM) x Average PEPM (annualized) U.S. Subscription Access Fees • Reported in aggregate for global business lines I
Slide 98: KPIs: Reported and Pro Forma
KPIs: Reported and Pro Forma PEPM Members (M) 23 20 20 $1.01 $0.94 $0.95 $0.97 18 $0.91 $0.91 18 17 17 17 14 14 $0.59 $0.61 $0.58 $0.55 (2) 3Q'16 4Q'16 1Q'17 2Q'17 3Q'17 3Q'16 4Q'16 1Q'17 2Q'17 3Q'17 (1) (1) Pro Forma PEPM PEPM as Reported Pro Forma U.S. Paid Members Members as Reported (1) Calculat
Slide 99: Balance Sheet
Balance Sheet Liquidity Debt Cash & marketable securities: +$160M Debt Rate Fair Value Outstanding Senior Debt 8.7% (1) $167M $175M Convertible Debt 3.0% $204M $275M Covenants – Senior Term Loan Facility • Minimum LTM revenue growth • Minimum liquidity Significant Cushion for Covenants (1) Senior de
Slide 100: Teladoc: Reaffirming Guidance
Teladoc: Reaffirming Guidance ($ in millions, except per share data) Q4 2017 FY 2017 Revenue $75 – $77 $231 – $233 Adjusted EBITDA $1 – $2 ($13) – ($14) Visits (K) (1) 400 – 450 1,400 – 1,450 Members (M) (1) 22.6 – 23.0 22.6 – 23.0 EPS (GAAP) ($0.41) – ($0.43) ($1.56) – ($1.58) ~90% visibility into

Teladoc Health — Investor Day (November 2017) on 6ix

Teladoc Health — Investor Day (November 2017)

Slide 1: Agenda

Slide 2: Teladoc Overview

Slide 3: Leading the Way in Virtual Care Delivery

Slide 4: Investment Highlights

Slide 5: Teladoc at a Glance

Slide 6: Execution on Growth Strategy

Slide 7: Executing Multi-Faceted Growth Strategy

Slide 8: TAM Expansion & Significant Penetration Opportunity

Slide 9: Redefined Competitive Landscape

Slide 10: Revenue Upside w/ Long Term Partner

Slide 11: Case Study: Health Plan with Utilization-Based Upside

Slide 12: New Business Wins

Slide 13: Integrated Commercial Strategy

Slide 14: Peter McClennen

Slide 15: © 2002-2017 Teladoc, Inc. All rights reserved.

Slide 16: Misdiagnosis: A Global Health Challenge

Slide 17: Best Doctors Value Proposition

Slide 18: What is Best Doctors?

Slide 19: Best Doctors Global Business Model

Slide 20: Teladoc and Best Doctors

Slide 21: Solving the Most Complex & Costliest Cases

Slide 22: Teladoc's Unique Commercial Focus

Slide 23: Realizing Our Integrated Offering

Slide 24: Massive Whitespace

Slide 25: Cross-Selling Integrated Solution: Early Wins

Slide 26: Questions?

Slide 27: Clinical Quality & Health Services

Slide 28: Lewis Levy, MD, FACP

Slide 29: Access to the Best Doctors Globally

Slide 30: Expert Opinion: Clinical Process

Slide 31: Expert Opinion: Member Experience

Slide 32: Best Doctors Patient Case Study

Slide 33: Best Doctors Results

Slide 34: Accelerating Quality of Cancer Care

Slide 35: Teladoc's Unmatched Clinical Quality

Slide 36: Engagement Strategy

Slide 37: Stephany Verstraete

Slide 38: Path to Inflection Point

Slide 39: Path to Inflection Point

Slide 40: Phase 1: Reaching Early Adopters

Slide 41: Teladoc Media Mix

Slide 42: Phase 2: Mainstream Acceptance

Slide 43: Teladoc Media Mix

Slide 44: Sophisticated Audience Intelligence Fuels Utilization

Slide 45: Sophisticated Audience Intelligence Fuels Reach

Slide 46: Sophisticated Audience Intelligence Fuels Targeting

Slide 47: Sophisticated Audience Intelligence Fuels Personalization

Slide 48: Member Journey Video

Slide 49: Sophisticated Engagement Strategies Yield Stronger Results

Slide 50: Install Base Utilization Tailwinds

Slide 51: Teladoc Media Mix: What's Next?

Slide 52: What's Next? Messaging

Slide 53: What's Next? Access Proliferation Continues

Slide 54: Questions?

Slide 55: 20 Minute Break

Slide 56: Product Vision

Slide 57: Dan Trencher

Slide 58: Path to Inflection Point: Product

Slide 59: The Experience Consumers Expect

Slide 60: Building a Virtual Healthcare Ecosystem

Slide 61: Building a Virtual Healthcare Ecosystem

Slide 62: Building a Virtual Healthcare Ecosystem

Slide 63: Building a Virtual Healthcare Ecosystem

Slide 64: Building a Virtual Healthcare Ecosystem

Slide 65: Building a Virtual Healthcare Ecosystem

Slide 66: Integrated, Personalized, Relevant

Slide 67: An Expanding Product Portfolio

Slide 68: An Expanding Product Portfolio

Slide 69: An Expanding Product Portfolio

Slide 70: Innovative New Products

Slide 71: New Digital Engagement Features

Slide 72: Demo of New Integrated Mobile App

Slide 73: Vision – Illustrative Integrated User Experience

Slide 74: Vision – Illustrative Integrated User Experience

Slide 75: Client Insights

Slide 76: Chet Burrell

Slide 77: About CareFirst

Slide 78: Best Doctors Partnership

Slide 79: Matt Ponicall